Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
The measure definition follows the guidelines in the American College of Cardiology/American Heart Association Guidelines for the Management of Patients with (ST-Elevation) Myocardial Infarction. The time-to-treatment recommendations in these Guidelines start with when the patient presents to the medical system.
STEMI patients were excluded if they were transferred in or had a non-system reason to delay fibrinolytic therapy.
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
In 2014, race/ethnicity data were displayed for all groups for which statistically reliable data are available. Some race/ethnicity groups were mistakenly suppressed at the launch due to a database error.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link